ABSTRACT
Cancer stands as one of the deadliest diseases in human history, marked by an inferior prognosis. While traditional therapeutic methods like surgery, chemotherapy, and radiation have demonstrated success in inhibiting tumor cell growth, their side effects often limit overall benefits and patient acceptance. In this regard, three different graphene oxides (GO) with variations in their degrees of oxidation were studied chemically and tissue-wise. The accuracy of the synthesis of the different GO was verified by robust techniques using X-ray photoelectron spectroscopy (XPS), as well as conventional techniques such as infrared spectroscopy (FTIR), RAMAN spectroscopy, and X-ray diffraction (XRD). The presence of oxygenated groups was of great importance. It affected the physicochemical properties of each of the different graphene oxides demonstrated in the presence of new vibrational modes related to the formation of new bonds promoted by the graphitization of the materials. The toxicity analysis in the Hep-2 cell line of graphene oxide formulations at 250 µg/mL on the viability and proliferation of these tumor cells showed low activity. GO formulations did not show high antibacterial activity against Staphylococcus aureus and Escherichia coli strains. However, the different graphene oxides showed biocompatibility in the subdermal implantation model for 30, 60, and 90 days in the biomodels. This allowed healing by restoring hair and tissue architecture without triggering an aggressive immune response.
Subject(s)
Graphite , Uterine Cervical Neoplasms , Humans , Female , Graphite/pharmacology , Anti-Bacterial Agents/pharmacology , Escherichia coli , Oxides/pharmacologyABSTRACT
Introducción: El zinc es uno de los micronutrientes esenciales en el organismo por intervenir en numerosos procesos biológicos como el crecimiento y desarrollo, siendo de especial importancia durante el periodo de gestación. Objetivo: Determinar los niveles de zinc urinario en gestantes del municipio de Baranoa del (Atlántico) por el método colorimétrico utilizando zincon (MCZ) y el método de espectrofotometría de absorción atómica (MEAA) y comparar los niveles de zinc urinario por el método de MCZ y MEAA. Métodos: Se estudiaron 54 gestantes entre 24 y 30 años de edad, las cuales fueron atendidas en el Hospital José Gómez Heredia del municipio de Baranoa (Atlántico), entre los meses de enero a agosto del año 2008 cuando se encontraban en las semanas 8-15, 20-25 y 32-36 de la gestación. Las gestantes llenaron una encuesta acerca de datos generales que incluye edad e historia patológica y entregaron muestras de orina durante los tres trimestres de gestación. Las muestras fueron colectadas en ayuna de 12 horas y conservadas a -20°C. Luego se determinó el zinc urinario por el MEAA y MCZ. Resultados: Los niveles totales de zinc urinario fueron de 16.2±7 μg/dL por MCZ y 25±16 μg/dL por MEAA, se encontró que el zinc urinario fue de 17.81±5.20 μg/dL, 16±6.50 μg/dL y 14.30±9.05 μg/dL, para el primero, segundo y tercer trimestre de gestación por MCZ y 27.2 ± 16.8μg/dL, 19.8 ± 14.9b μg/dL, 27.3 ± 14.5a μg/dL, para el primero, segundo y tercer trimestre de gestación por MEAA. Los niveles de Zn determinados por MCZ y MEAA presentaron diferencias estadísticamente significativas (p≤0.05), indicando que el MEAA detecta mejor la excreción de Zn. Pero el MCZ propuesto se puede utilizar para estudios a largo plazo. Conclusiones: El comportamiento del zinc urinario en la gestación mostró variaciones, hallando las concentraciones de zinc urinario más bajo en el segundo y tercer trimestre de la gestación
Introduction: Zinc is one of the essential micronutrients in the organism for intervening in numerous biological processes such as growth and development, being of special importance during the gestation period. Objective: To determine the levels of urinary zinc in pregnant women of the municipality of Baranoa del (Atlántico) by the colorimetric method using zincon (MCZ) and the method of atomic absorption spectrophotometry (MEAA) and to compare the levels of urinary zinc by the MCZ method and MEAA. Methods: Fifty-four pregnant women between 24 and 30 years of age were studied, who were treated at the José Gómez Heredia Hospital in the municipality of Baranoa (Atlántico), between the months of January and August 2008 when they were found in weeks 8- 15, 20-25 and 32-36 of gestation. Participants completed a survey on general data including age and pathological history and delivery of urine samples during the three trimesters of pregnancy. Samples were collected in a 12-hour fast and stored at -20°C. Urinary zinc was then determined by the MEAA and MCZ. Results: The total urinary zinc levels were 16.2 ± 7 μg / dL per MCZ and 25 ± 16 μg / dL per MEAA, the urinary zinc was found to be 17.81 ± 5.20 μg / dL, 16 ± 6.50 μg / dL and 14.30 ± 9.05 μg / dL, for the first, second and third trimesters of pregnancy by MCZ and 27.2 ± 16.8μg / dL, 19.8 ± 14.9b μg / dL, 27.3 ± 14.5a μg / dL, for the first, second and third trimesters of gestation by MEAA. Zn levels determined by MCZ and MEAA showed statistically significant differences (p≤0.05), indicating that MEAA better detects Zn excretion. But the proposed MCZ can be used for long-term studies. Conclusions: The behavior of urinary zinc in pregnancy showed variations, finding the concentrations of urinary zinc lower in the second and third trimesters of gestation
